Elevance Health (ELV) Competitors

$547.71
+3.82 (+0.70%)
(As of 05/17/2024 ET)

ELV vs. CI, HUM, CNC, UNH, SYK, SNY, ISRG, MDT, VRTX, and REGN

Should you be buying Elevance Health stock or one of its competitors? The main competitors of Elevance Health include The Cigna Group (CI), Humana (HUM), Centene (CNC), UnitedHealth Group (UNH), Stryker (SYK), Sanofi (SNY), Intuitive Surgical (ISRG), Medtronic (MDT), Vertex Pharmaceuticals (VRTX), and Regeneron Pharmaceuticals (REGN). These companies are all part of the "medical" sector.

Elevance Health vs.

The Cigna Group (NYSE:CI) and Elevance Health (NYSE:ELV) are both large-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, analyst recommendations, earnings, risk, profitability, institutional ownership, dividends, valuation and community ranking.

The Cigna Group has a beta of 0.57, indicating that its stock price is 43% less volatile than the S&P 500. Comparatively, Elevance Health has a beta of 0.79, indicating that its stock price is 21% less volatile than the S&P 500.

The Cigna Group received 97 more outperform votes than Elevance Health when rated by MarketBeat users. Likewise, 71.86% of users gave The Cigna Group an outperform vote while only 66.61% of users gave Elevance Health an outperform vote.

CompanyUnderperformOutperform
The Cigna GroupOutperform Votes
927
71.86%
Underperform Votes
363
28.14%
Elevance HealthOutperform Votes
830
66.61%
Underperform Votes
416
33.39%

The Cigna Group pays an annual dividend of $5.60 per share and has a dividend yield of 1.7%. Elevance Health pays an annual dividend of $6.52 per share and has a dividend yield of 1.2%. The Cigna Group pays out 46.0% of its earnings in the form of a dividend. Elevance Health pays out 24.6% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. The Cigna Group has raised its dividend for 4 consecutive years and Elevance Health has raised its dividend for 13 consecutive years.

Elevance Health has lower revenue, but higher earnings than The Cigna Group. Elevance Health is trading at a lower price-to-earnings ratio than The Cigna Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
The Cigna Group$204.15B0.47$5.16B$12.1827.81
Elevance Health$171.34B0.74$5.99B$26.4620.70

87.0% of The Cigna Group shares are owned by institutional investors. Comparatively, 89.2% of Elevance Health shares are owned by institutional investors. 0.6% of The Cigna Group shares are owned by company insiders. Comparatively, 0.4% of Elevance Health shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Elevance Health has a net margin of 3.64% compared to Elevance Health's net margin of 1.76%. The Cigna Group's return on equity of 20.62% beat Elevance Health's return on equity.

Company Net Margins Return on Equity Return on Assets
The Cigna Group1.76% 17.24% 5.09%
Elevance Health 3.64%20.62%7.35%

The Cigna Group currently has a consensus price target of $366.14, suggesting a potential upside of 8.10%. Elevance Health has a consensus price target of $587.42, suggesting a potential upside of 7.25%. Given Elevance Health's higher probable upside, equities analysts clearly believe The Cigna Group is more favorable than Elevance Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
The Cigna Group
0 Sell rating(s)
2 Hold rating(s)
10 Buy rating(s)
1 Strong Buy rating(s)
2.92
Elevance Health
0 Sell rating(s)
1 Hold rating(s)
12 Buy rating(s)
0 Strong Buy rating(s)
2.92

In the previous week, The Cigna Group had 4 more articles in the media than Elevance Health. MarketBeat recorded 17 mentions for The Cigna Group and 13 mentions for Elevance Health. The Cigna Group's average media sentiment score of 1.09 beat Elevance Health's score of 0.93 indicating that Elevance Health is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
The Cigna Group
10 Very Positive mention(s)
3 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Elevance Health
7 Very Positive mention(s)
4 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Elevance Health beats The Cigna Group on 12 of the 21 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ELV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ELV vs. The Competition

MetricElevance HealthHospital & medical service plans IndustryMedical SectorNYSE Exchange
Market Cap$127.30B$68.33B$5.31B$18.07B
Dividend Yield1.20%1.32%43.94%3.44%
P/E Ratio20.7022.86151.1626.21
Price / Sales0.740.562,354.9511.64
Price / Cash13.1910.5036.7319.45
Price / Book3.134.085.746.01
Net Income$5.99B$3.04B$106.98M$966.65M
7 Day Performance1.58%3.02%1.41%1.85%
1 Month Performance3.03%14.30%4.94%6.59%
1 Year Performance19.63%281.65%7.83%23.69%

Elevance Health Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CI
The Cigna Group
4.8123 of 5 stars
$346.17
-0.9%
$366.14
+5.8%
+32.1%$98.34B$195.27B28.4272,500Insider Selling
Short Interest ↓
HUM
Humana
4.9723 of 5 stars
$344.50
+1.4%
$424.50
+23.2%
-30.7%$41.51B$109.24B21.4567,600
CNC
Centene
4.6034 of 5 stars
$76.85
-0.4%
$85.23
+10.9%
+18.6%$41.01B$154.00B15.2867,700Insider Selling
Analyst Revision
UNH
UnitedHealth Group
4.9078 of 5 stars
$513.88
+0.4%
$570.05
+10.9%
+9.5%$472.97B$371.62B31.41440,000News Coverage
SYK
Stryker
4.8654 of 5 stars
$324.30
-0.1%
$365.94
+12.8%
+17.3%$123.54B$20.50B37.0252,000
SNY
Sanofi
2.8823 of 5 stars
$49.50
-1.4%
$55.00
+11.1%
-9.6%$125.22B$46.61B24.8786,088Analyst Revision
ISRG
Intuitive Surgical
4.5994 of 5 stars
$384.19
+0.9%
$396.17
+3.1%
+27.7%$136.27B$7.12B69.3513,676Insider Selling
Short Interest ↑
MDT
Medtronic
4.5602 of 5 stars
$84.29
+0.9%
$94.91
+12.6%
-3.5%$111.92B$31.23B26.8495,000Upcoming Earnings
News Coverage
VRTX
Vertex Pharmaceuticals
4.1573 of 5 stars
$428.59
-0.3%
$432.18
+0.8%
+31.2%$110.60B$9.87B27.815,400Analyst Upgrade
REGN
Regeneron Pharmaceuticals
4.0575 of 5 stars
$984.64
+0.8%
$981.71
-0.3%
+31.4%$108.50B$13.12B29.0913,450Analyst Forecast
Insider Selling
News Coverage

Related Companies and Tools

This page (NYSE:ELV) was last updated on 5/19/2024 by MarketBeat.com Staff

From Our Partners